PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief User Manual

June 4, 2024
PROSPECT FARMS

Presenting you the Prospect Farms
‘Dream Topical – Extra Strength’

WELLNESS IS ROOTED IN TRUST AND AUTHENTICITY
A Comprehensive Guide to Certificates of Analysis (COAs)

Our Seed to Store Promise: Transparent Lab Analysis

Prospect Farms’ commitment to traceability and sustainable agriculture practices ensures every facet of the process, from farming to manufacturing, is done with the utmost care and transparency. From seed to store, everything happens right here on our farm in Prospect, Maine.PROSPECT FARMS 1500mg CBD
Dream Topical-Nighttime Relief - Figer1

HEMP FLOWER

Cannabinoid Profile & Potency PASS
Pathogenic Bacterial Contaminants PASS
Mycotoxin Testing PASS
Terpenes Profile PASS

HEMP EXTRACT

Cannabinoid Profile & Potency PASS
Heavy Metal Analysis PASS
Microbiological Contaminants PASS
Pathogenic Bacterial Contaminants PASS
Mycotoxin Testing PASS
Pesticide Analysis PASS
Terpenes Profile PASS
Analysis of Volatile Organic Compounds PASS

FINAL PRODUCT

Cannabinoid Profile & Potency PASS
Terpenes Profile (if applicable) PASS

A HOLISTIC APPROACH TO WELLNESS

At Prospect Farms we believe wellness is rooted in trust and authenticity, so from our farming practices to the ingredients included in each of our products, we have nothing to hide. Quality Full-Spectrum CBD starts as a seed, not on the shelf. That is why we genetically select each and every seed that goes into our nutrient-rich soil in Prospect, Maine. We follow strict organic farming practices including the use of regenerative cover crops to ensure a healthy, natural environment for each and every hemp plant. We hand-harvest, slow dry, and carefully process the hemp plants all on our farm to ensure the quality preservation of true full spectrum CBD. Transparency isn’t a buzzword, it’s an ideology we live by daily.

TESTED, TRUSTED & TRANSPARENT

Rigorous quality control is required in every aspect of the supply chain. We are the farm. We are the processor. We are the manufacturing support to bring to market truly clean, green skincare. Because of this, we are among the few who are able to meticulously validate each and every step from Seed to Store. Through peer-leading, 3rd party, ISO-accredited labs, we use leading-edge technology to test each and every batch to ensure your products are receiving the highest standard of care and validation.

LAB ANALYSIS

TRULY transparent means we test upwards of 14 times across a broad spectrum of lab analysis to support TRUE quality. We ensure your product is free from mycotoxins, heavy metals, microbiological contaminants, bacterial contaminants, pesticides, and residual solvents (volatile organic compounds). Truly clean means non-detectable and transcends industry norms to establish a new quality standard for the industry.

Certificate of Analysis Summary

Laboratory Certificate: ProVerde Laboratories
Manufacturing Date: 6/21| Expiration Date: 6/23| Lab Analysis Date: 6/21
Manufacturer Country: USA| Hemp License State: Maine| UPC: 850014532260
All results were collected in accordance with the requirements of ISO/ EC 17025:2017.
Brand| Prospect Farms
---|---
Product| Dream
Ritual| Nighttime
Strength| Extra Strength
Volume| 2.0 FL OZ / 60 ML
Cannabinoid Analysis| STATUS
---|---
Total THC*| PASS
Total CBD| PASS

*Less than 0.3% in Dry weight basis measurement for Federal Compliancy

HEMP FLOWER STATUS
Cannabinoid Profile & Potency PASS
Pathogenic Bacterial Contaminants PASS
Mycotoxin Testing PASS
Terpenes Profile PASS
HEMP EXTRACT STATUS
--- ---
Cannabinoid Profile & Potency PASS
Heavy Metal Analysis PASS
Microbiological Contaminants PASS
Pathogenic Bacterial Contaminants PASS
Mycotoxin Testing PASS
Pesticide Analysis PASS
Terpenes Profile PASS
Analysis of Volatile Organic Compounds PASS
FINAL PRODUCT STATUS
--- ---
Cannabinoid Profile & Potency PASS
Terpenes Profile (if applicable) PASS

Certificate ID: 68782 (Prelim)
Received: 10/23/19
Client Sample ID: PF Biomass sample 1
Lot Number: 1
Matrix: Flowers/Bud – Dry Flower

Scan QR Code for authenticity

https://orders.proverdelabs.com/utils/results.ashx?o=24624&c=8822&cc=9490&s=79948

Prospect Farms Industrial Hemp Group, LLC
6 Partridge Rd Prospect, ME 04981
Attn: Thomas Arters

Authorization:
Jon Podgorny, Lead Research Chemist| PROSPECT FARMS 1500mg CBD Dream
Topical-Nighttime Relief - signature| Date:
11/6/2019
---|---|---

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer2

The data contained within this report was collected in accordance with the requirements of ISO/1EC17025:2017. I attest that the information contained within the report has been reviewed for accuracy and checked against the quality control requirements for each method. These results relate only to the test article listed in this report. Reports may not be reproduced except in their entirety.

CN: Cannabinoid Profile & Potency [WI-10-17 & WI-10-17-01] Analyst: JSG
Test Date: 11/3/2019

The client sample was analyzed for plant-based cannabinoids by Liquid Chromatography (LC). The collected data was compared to data collected for certified reference standards at known concentrations.
68782-CN

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer3

The ratio of Total CBD to THC 29.4:1
Limit of Quantitation (LOQ) = 0.007 wt%
Max THC (and Max CBD) are calculated values for total cannabinoids after heating, assuming complete decarboxylation of the acid to the neutral form. It is calculated based on the weight loss of the acid group during decarboxylation: Max THC = (0.877 x THCA) + THC. This calculation does not include other cannabinoid isomers (eg. D8-THC and exo-THC). ND = None detected above the limits of detection (LOD), which is half of LOQ.

MY: Mycotoxin Testing [WI-10-05] Analyst: AKR
Test Date: 10/31/2019
This test method was performed in accordance with the requirements of ISO/IEC 17025. These results relate only to the test article listed in this report. Reports may not be reproduced except in their entirety.
68782-MY

Test ID Date Results MDL Limits **Status***
Total Aflatoxin 10/31/2019 < MDL 2 ppb < 20 ppb PASS
Total Ochratoxin 10/31/2019 < MDL 3 ppb < 20 ppb PASS

TP: Terpenes Profile [WI-10-27] Analyst: JR
Test Date: 10/30/2019
The client sample was analyzed by Head-Space Gas Chromatography (HS-GC). The collected data were compared to data collected for certified reference standards at known concentrations. All values are semiquantitative estimates based on recorded peak areas relative to terpene calibration data.
68782-TP
PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer4 Certificate ID: 68783 (Prelim)
Received: 10/23/19
Client Sample ID: PF B Flower Sample 1
Lot Number: 1
Matrix: Flowers/Bud – Dry Flower

https://orders.proverdelabs.com/utils/results.ashx?o=24624&c=8822&cc=9490&s=79949

Prospect Farms Industrial Hemp Group, LLC
6 Partridge Rd
Prospect, ME 04981
Attn: Thomas Arters

Authorization:
Jon Podgorny, Lead Research Chemist| PROSPECT FARMS 1500mg CBD Dream
Topical-Nighttime Relief - signature| Date:
11/6/2019
---|---|---

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer5

The data contained within this report was collected in accordance with the requirements of ISO/1EC17025:2017. I attest that the information contained within the report has been reviewed for accuracy and checked against the quality control requirements for each method. These results relate only to the test article listed in this report. Reports may not be reproduced except in their entirety.

CN: Cannabinoid Profile & Potency [WI-10-17 & WI-10-17-01] Analyst: JSG
Test Date: 11/3/2019

The client sample was analyzed for plant-based cannabinoids by Liquid Chromatography (LC). The collected data was compared to data collected for certified reference standards at known concentrations.
68783-CN

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer6

Ratio of Total CBD to THC 31.3:1
Limit of Quantitation (LOQ) = 0.007 wt%
Max THC (and Max CBD) are calculated values for total cannabinoids after heating, assuming complete decarboxylation of the acid to the neutral form. It is calculated based on the weight loss of the acid group during decarboxylation: Max THC = (0.877 x THCA) + THC. This calculation does not include other cannabinoid isomers (eg. D8-THC and exo-THC). ND = None detected above the limits of detection (LOD), which is half of LOQ.

MB2: Pathogenic Bacterial Contaminants [WI-10-10]
Analyst: LabAdmin
Test Date: 10/29/2019
This test method was performed in accordance with the requirements of ISO/IEC 17025. These results relate only to the test article listed in this report. Reports may not be reproduced except in their entirety.
68783-MB2

Test ID| Analysis| Results| Units| **Limits*| Status**
---|---|---|---|---|---
68783-ECPT| E. coli (O157)| Negative| NA| Non Detected| PASS
68783-SPT| Salmonella| Negative| NA| Non Detected| PASS

Note: All recorded pathogenic bacteria tests passed.

TP: Terpenes Profile [WI-10-27]
Analyst: JR
Test Date: 10/30/2019
The client sample was analyzed by Head-Space Gas Chromatography (HS-GC). The collected data was compared to
data collected for certified reference standards at known concentrations. All values are semiquantitative estimates based
on recorded peak areas relative to terpene calibration data.
68783-TP

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer7

Certificate ID: 93682 (Reissued)
Received: 3/31/21
Client Sample ID: PF Full-Spectrum Hemp Extract Oil
Lot Number: PF0100
Matrix: Concentrates/Extracts – Butane

https://orders.proverdelabs.com/utils/results.ashx?o=35471&c=8822&cc=10635&s=113510

Authorization:
Chris Hudalla, Chief Science Officer| PROSPECT FARMS 1500mg CBD Dream
Topical-Nighttime Relief - signature2| Date:
8/10/2021
---|---|---

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer8

The data contained within this report was collected in accordance with the requirements of ISOREC17025:2017. I attest that the information contained within the report has been reviewed for accuracy and checked against the quality control requirements for each method. These results relate only to the test article listed in this report. Reports may not be reproduced except in their entirety.

CN: Cannabinoid Profile & Potency [WI-10-17 & WI-10-17-01]
Analyst: AC
Test Date: 4/4/2021
The client sample was analyzed for plant-based cannabinoids by Liquid Chromatography (LC). The collected data was compared to data collected for certified reference standards at known concentrations.
93682-CN

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer9

The ratio of Total CBD to THC 27.7:1
Max THC (and Max CBD) are calculated values for total cannabinoids after heating, assuming complete decarboxylation of the acid to the neutral form. It is calculated based on the weight loss of the acid group during decarboxylation: MAX THC = (0.877 x THCA) + THC. This calculation does not include other cannabinoid isomers (eg. D8-THC and exo-THC). ND=None detected above the limits of detection (LOD), which is one-third of the Limit of Quantification (LOQ). For values reported as “<LOQ”, the estimated value is included in the calculated Total.

HM: Heavy Metal Analysis [WI-10-13]
Analyst: CJS
Test Date: 4/13/2021
This test method was performed in accordance with the requirements of ISO/IEC 17025. These results relate only to the test article listed in this
report. Reports may not be reproduced except in their entirety.
93682-HM

| | | |

Use Limits2 (µg/kg)

|
---|---|---|---|---|---
Symbol| Metal| Conc.(µg/kg)| RL| All| Ingestion| Status
As| Arsenic| ND| 50.0| 200| 500| PASS
Cd| Cadmium| ND| 50.0| 200| 1,500| PASS
Hg| Mercury| ND| 50.0| 100| 1,500| PASS
Pb| Lead| ND| 50.0| 500| 1,000| PASS

  1. ND = None detected above the indicated Reporting Limit (RL)
  2. MA Dept. of Public Health: Protocol for MMJ and MIPS, Exhibit 4(a) for all products.
  3. USP exposure limits based on daily oral dosing of 1g of concentrate for a 110 lb person.

MB1: Microbiological Contaminants [WI-10-09]
Analyst: MM
Test Date: 4/6/2021
This test method was performed in accordance with the requirements of ISO/IEC 17025. These results relate only to the test article listed in this report. Reports may not be reproduced except in their entirety.
93682-MB1

Symbol| Analysis| Results| Units| **Limits*| Status**
---|---|---|---|---|---
AC| Total Aerobic Bacterial Count| <100| CFU/g| 10,000 CFU/g| PASS
CC| Total Coliform Bacterial Count| <100| CFU/g| 100 CFU/g| PASS
EB| Total Bile Tolerant Gram Negative Count| <100| CFU/g| 100 CFU/g| PASS
YM| Total Yeast & Mold| <100| CFU/g| 1,000 CFU/g| PASS

Recommended limits were established by the American Herbal Pharmacopoeia (AHP) monograph for Cannabis Inflorescence [2013], for consumable botanical products, including processed and unprocessed cannabis materials, and solvent- based extracts. Note: All recorded Microbiological tests are within the established limits.

MB2: Pathogenic Bacterial Contaminants [WI-10-10]
Analyst: MM
Test Date: 4/7/2021
This test method was performed in accordance with the requirements of ISO/IEC 17025. These results relate only to the test article listed in this
report. Reports may not be reproduced except in their entirety.
93682-MB2

Test ID| Analysis| Results| Units| **Limits*| Status**
---|---|---|---|---|---
93682-ECPT| E. coli (O157)| Negative| NA| Non Detected| PASS
93682-SPT| Salmonella| Negative| NA| Non Detected| PASS

Note: All recorded pathogenic bacteria tests passed.

MY: Mycotoxin Testing [WI-10-05]
Analyst: SLC
Test Date: 4/13/2021
This test method was performed in accordance with the requirements of ISO/IEC 17025. These results relate only to the test article listed in this report. Reports may not be reproduced except in their entirety.
93682-MY

Test ID Date Results MDL Limits **Status***
Total Aflatoxin 4/13/2021 < MDL 2 ppb < 20 ppb PASS
Total Ochratoxin 4/13/2021 < MDL 3 ppb < 20 ppb PASS

PST: Pesticide Analysis [WI-10-11]
Analyst: CJS
Test Date: 4/28/2021
The client sample was analyzed for pesticides using Liquid Chromatography with Mass Spectrometric detection (LC/MS/MS). The method used for sample prep was based on the European method for pesticide analysis (EN 15662).
93682-PST

Analyte| CAS| Result| Units| LLD| Limits (ppb)| Status
---|---|---|---|---|---|---
Abamectin| 71751-41-2| ND| ppb| 0.2| 10| PASS
Spinosad| 168316-95-8| ND| ppb| 0.1| 10| PASS
Pyrethrin| 8003-34-7| ND| ppb| 0.1| 10| PASS
Trifloxystrobin| 141517-21-7| ND| ppb| 0.1| 100| PASS
Spirotetramat| 203313-25-1| ND| ppb| 0.1| 100| PASS
Spiromesifen| 283594-90-1| ND| ppb| 0.1| 100| PASS
Piperonyl butoxide| 51-03-6| ND| ppb| 0.1| 3000| PASS
Paclobutrazol| 76738-62-0| ND| ppb| 0.1| 10| PASS
Myclobutanil| 88671-89-0| ND| ppb| 0.1| 100| PASS
Imidacloprid| 138261-41-3| ND| ppb| 0.1| 5000| PASS
Imazalil| 35554-44-0| ND| ppb| 0.1| 10| PASS
Fenoxycarb| 72490-01-8| ND| ppb| 0.1| 10| PASS
Etoxazole| 153233-91-1| ND| ppb| 0.1| 100| PASS
Dichlorvos| 62-73-7| ND| ppb| 3| 10| PASS
Cyfluthrin| 68359-37-5| ND| ppb| 0.5| 2000| PASS
Bifenthrin| 82657-04-3| ND| ppb| 0.2| 3000| PASS
Bifenazate| 149877-41-8| ND| ppb| 0.1| 100| PASS
Azoxystrobin| 131860-33-8| ND| ppb| 0.1| 100| PASS

  • Testing limits established by the Massachusetts Department of Public Health, Protocol for Sampling and Analysis of Finished Medical Marijuana Products and Marijuana-Infused Products for Massachusetts Registered Medical Marijuana Dispensaries, Exhibit 5. ND indicates “none detected” above the lower limit of detection (LLD). Analytes marked with (*) indicate analytes for which no recovery was observed for a pre-spiked matrix sample due to matrix interference.

TP: Terpenes Profile [WI-10-27]
Analyst: LC
Test Date: 4/17/2021
Client sample analysis was performed using full evaporative technique (FET) headspace sample delivery and gas chromatographic (GC) compound separation. A combination of flame ionization detection (FID) and/or mass spectrometric (MS) detection with mass spectral confirmation against the National Institute of Standards and Technology (NIST) Mass Spectral Database, Revision 2017 were used. Chromatographic and/or mass spectral data were processed by quantitatively comparing the analytical peak areas against calibration curves prepared from certified reference standards.
93682-TP

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer10

  • Certified reference standard not available for this compound. Concentration is estimated using the response factor from alpha-pinene. ND = None
    Detected. RL = Reporting Limit of 5 ppm.

VC: Analysis of Volatile Organic Compounds [WI-10-28]
Analyst: CJS
Test Date: 8/6/2021
The client sample was analyzed by Head-Space Gas Chromatography (HS-GC). The collected data were compared to data collected for certified reference standards at known concentrations. The certificate has been re-issued with results from retesting of residual solvents.
93682-VC (retest)

Compound CAS Amount¹ Limit² RL Status
Propane 74-98-6 ND 1,000 ppm 100 PASS
Isobutane 75-28-5 ND 1,000 ppm 100 PASS
Butane 106-97-8 ND 1,000 ppm 100 PASS
Methanol 67-56-1 ND 3,000 ppm 100 PASS
Pentane 109-66-0 ND 5,000 ppm 100 PASS
Ethanol 64-17-5 ND 5,000 ppm 100 PASS
Acetone 67-64-1 ND 5,000 ppm 100 PASS
Isopropanol 67-63-0 ND 5,000 ppm 100 PASS
Acetonitrile 75-05-8 ND 410 ppm 100 PASS
Hexane 110-54-3 ND 290 ppm 100 PASS
Heptane 142-82-5 ND 5,000 ppm 100 PASS
  1. ND = Not detected at a level greater than the Reporting Limit (RL).
  2. In ppm, based on USP recommended limits for residual solvents, adopted by the Massachusetts Department of Public Health for cannabis concentrates and extracts on 3/31/16. Butane/Propane limits are based on limits established for the state of Colorado.
    (*) For ethanol, as many formulations contain flavorings based on ethanol extracts of natural products, no status has been assigned.

Certificate ID: 95534
Received: 6/21/21
Client Sample ID: Dream Topical – Extra Strength
Lot Number:
Matrix: Topicals – Salve

https://orders.proverdelabs.com/utils/results.ashx?o=35643&c=8822&cc=10635&s=115707

Authorization:
Chris Hudalla, Chief Science Officer| PROSPECT FARMS 1500mg CBD Dream
Topical-Nighttime Relief - signature2| Date:
6/25/2021
---|---|---

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer11

The data contained within this report was collected in accordance with the requirements of ISO/IEC17025:2017. I attest that the information contained within the report has been reviewed for accuracy and checked against the quality control requirements for each method. These results relate only to the test article listed in this report. Reports may not be reproduced except in their entirety.

CN: Cannabinoid Profile & Potency [WI-10-17 & WI-10-17-01]
Analyst: AC
Test Date: 6/23/2021
The client sample was analyzed for plant-based cannabinoids by Liquid Chromatography (LC). The collected data was compared to data collected for certified reference standards at known concentrations.
95534-CN

PROSPECT FARMS 1500mg CBD Dream Topical-Nighttime Relief -
Figer12

The ratio of Total CBD to THC 29.9:1
Max THC (and Max CBD) are calculated values for total cannabinoids after heating, assuming complete decarboxylation of the acid to the neutral form. It is calculated based on the weight loss of the acid group during decarboxylation: MAX THC = (0.877 x THCA) + THC. This calculation does not include other cannabinoid isomers (eg. D8-THC and exo-THC). ND=None detected above the limits of detection (LOD), which is one-third of the Limit of Quantification (LOQ). For values reported as “<LOQ”, the estimated value is included in the calculated Total.

END OF REPORT
FM-10-10, Rev. 1, DCN:15-0003
420 Fortune Blvd • Milford, MA 01757 • 617-221-3356
www.ProVerdeLabs.com

References

Read User Manual Online (PDF format)

Read User Manual Online (PDF format)  >>

Download This Manual (PDF format)

Download this manual  >>

Related Manuals